Tag results:
rheumatoid arthritis
Endothelial Cell News
CXCL13/CXCR5 Axis Facilitates Endothelial Progenitor Cell Homing and Angiogenesis during Rheumatoid Arthritis Progression
[Cell Death & Disease] Rheumatoid arthritis synovial fluid increased endothelial progenitor cell homing and angiogenesis, which was blocked by the CXCL13 antibody.
Extracellular Matrix News
Disrupted Homeostasis of Synovial Hyaluronic Acid and Its Associations with Synovial Mast Cell Proteases of Rheumatoid Arthritis Patients and Collagen-Induced Arthritis Rats
[Immunologic Research] The authors explored the correlations between hyaluronic acid (HA) concentration versus mast cell proteases, or matrix metalloproteinase-2/9 and investigated the association of mast cell-specific proteases with disrupted synovial HA homeostasis in rheumatoid arthritis or collagen-induced arthritis rats.
ESC & iPSC News
A Genome-Engineered Bioartificial Implant for Autoregulated Anticytokine Drug Delivery
[Science Advances] Researchers used CRISPR-Cas9 genome editing of iPSCs to create a synthetic gene circuit that sensed changing levels of endogenous inflammatory cytokines to trigger a proportional therapeutic response.
Extracellular Matrix News
A Fructosylated Peptide Derived from a Collagen II T Cell Epitope for Long-Term Treatment of Arthritis (FIA-CIA) in Mice
[Scientific Reports] Researchers investigated arthritis development in male DBA/1 mice which were injected with bovine collagen II and human fibrinogen on days 0 and 21, leading to stable and reproducible disease induction in 100% of immunized mice.
Hematopoiesis News
Medexus Completes Enrollment in Phase IV Clinical Trial of IXINITY® Targeting Label Expansion for Pediatric Hemophilia B Patients
[Medexus Pharmaceuticals, Inc.] Medexus Pharmaceuticals, Inc. announced that is has completed enrollment in its Phase IV Clinical Trial of IXINITY®, targeting label expansion for pediatric hemophilia B patients.
ESC & iPSC News
Establishment of an Integration-Free Human Induced Pluripotent Stem Cell Line (TJCi001-a) from Normal Bone Marrow-Derived Mesenchymal Stem Cells
[Stem Cell Research] Scientists generated an induced pluripotent stem cells (iPSC) line from bone marrow-MSCs employing a non-integrating episomal vector. The generated iPSCs expressed pluripotency markers, showed a normal karyotype, and exhibited the potential for in vitro differentiation into three germ layers.